Advancing Cancer Innovation from Discovery to Patients
For years, the Asian Fund for Cancer Research Limited (AFCR) has believed that scientific discovery alone is not enough. Promising cancer discoveries need support to move beyond the laboratory toward translation, clinical development and ultimately patient benefit.
Through BIOHK and partnerships across Hong Kong’s biomedical ecosystem, AFCR has brought together researchers, clinicians, entrepreneurs, investors and industry leaders from Asia and around the world to strengthen the connections needed to move innovation forward.
Build Ecosystem for Impacts
Advance Translational Cancer Research
Discussions explore how advances in genomics, biomarkers, artificial intelligence, earlier detection and emerging treatments can move from research toward clinical application.
Connect Research and Entrepreneurship
Scientists, biotechnology companies, entrepreneurs and investors connect around pathways that can advance promising innovations and support future patient benefit.
Build Ecosystem for Impacts
Researchers, clinicians and scientific leaders share perspectives on cancer research, precision medicine and emerging biomedical technologies.
Advance Translational Cancer Research
Discussions explore how advances in genomics, biomarkers, artificial intelligence, earlier detection and emerging treatments can move from research toward clinical application.
Connect Research and Entrepreneurship
Scientists, biotechnology companies, entrepreneurs and investors connect around pathways that can advance promising innovations and support future patient benefit.
Discovery
Translation
Investment
Clinical Development
Patients
Discovery
Translation
Investment
Clinical Development
Patients
From Early Vision to Emerging Opportunity
AFCR’s Continuing Role in Hong Kong’s Biomedical Innovation Ecosystem
A Look Back: 2022 – 2026
A retrospective on AFCR’s early efforts to convene leaders around translational research, commercialization, capital, clinical development and patient impact – and why this work remains important today.
Explore More from AFCR at BIOHK
The Asian Fund for Cancer Research Limited supports innovative research and global collaboration designed to accelerate progress against cancer. Your support helps promising discoveries move closer to patients.
